Cariprazine and Troglitazone: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Cariprazine
Troglitazone
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's the situation. Cariprazine (Vraylar) is a medicine your body breaks down using a liver system called CYP3A4. Interestingly, that same system also creates the long-acting active forms of the drug that do a lot of the work. Troglitazone can speed up that liver system.
Because CYP3A4 both builds up and clears out cariprazine's active pieces, speeding it up makes the overall effect hard to predict. Your cariprazine might work differently than expected. This is a theoretical concern, so we don't have exact numbers. The good news: your care team can manage this by watching how you respond and tailoring your dose. Please talk with your pharmacist or doctor before changing anything.
Mechanism: Cariprazine is a CYP3A4 substrate; CYP3A4 governs both the formation and the elimination of its active metabolites (didesmethyl- and desmethyl-cariprazine). Troglitazone is a CYP3A4 inducer.
- Direction: Net effect on cariprazine exposure is unclear because CYP3A4 mediates both activation and clearance of the active moiety.
- Magnitude: Not quantified; not formally studied.
- Evidence: Theoretical.
- Onset: Unspecified (enzyme induction is typically delayed over days to weeks).
Management: Combination is not recommended per labeling. If used, monitor clinical response closely and individualize dosing. Consider an alternative non-inducing agent if clinically appropriate.
What happens
Effects on the cariprazine exposure has not been evaluated and the net effect is unclear
Interaction Deep Dive
It is advised against giving cariprazine (a substrate of CYP3A4) together with a CYP3A4 inducer. The active metabolites of cariprazine are both formed and cleared through CYP3A4. How CYP3A4 inducers influence cariprazine exposure has not been studied, so the overall outcome remains uncertain1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
What your care team may do:
- Consider whether a different medicine that doesn't affect the same liver enzyme could be used instead, since this combination is generally not recommended.
- Watch you more closely for any change in how well your cariprazine is working or for new side effects.
- Adjust and individualize your cariprazine dose based on how you respond.
What you should do: Keep taking both exactly as prescribed for now, and do not stop or change either one on your own. Bring this up with your pharmacist or prescriber so they can decide the safest plan for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Cariprazine and Troglitazone together?
Combining cariprazine with an enzyme inducer like troglitazone is not recommended because it may unpredictably change how well cariprazine works; ask your pharmacist or doctor about the best option. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Troglitazone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Troglitazone interaction managed?
What your care team may do: Consider whether a different medicine that doesn't affect the same liver enzyme could be used instead, since this combination is generally not recommended. Watch you more closely for any change in how well your cariprazine is working or for new side effects. Adjust and individualize your cariprazine dose based on how you respond. What you should do: Keep taking both exa… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Cariprazine or Troglitazone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Cariprazine
Keep reading about Troglitazone
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist